Πλοήγηση ανά Θέμα "bone density conservation agent"
Αποτελέσματα 1-4 από 4
-
Experience gained from the implementation of the fracture liaison service in Greece
(2020)Introduction: We present the second implementation of a fracture liaison service (FLS) at a national level in Greece. Methods: This was a multicenter prospective study, organized by the Hellenic Society for the Study of ... -
Failure in diagnosis and under-treatment of osteoporosis in elderly patients with fragility fractures
(2019)We evaluated whether osteoporosis is adequately managed and treated in patients suffering from fragility fractures. Factors that influenced osteoporosis diagnosis and treatment rates were also assessed. To this end, patients ... -
A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures
(2020)Background:Romosozumab is a bone-forming antibody that increases bone formation and decreases bone resorption. We conducted a double-blinded, randomized, phase-2, dose-finding trial to evaluate the effect of romosozumab ... -
Romosozumab in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture: A Randomized Phase-2 Study
(2020)BACKGROUND: Romosozumab is an antibody that binds and inhibits sclerostin, thereby increasing bone formation and decreasing bone resorption. A double-blinded, randomized, phase-2, dose-finding trial was performed to evaluate ...
![No Thumbnail [100%x150]](data:image/svg+xml;base64,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)